NASDAQ
No price data available for this timeframe.
Beam Therapeutics Inc. (BEAM) has a price/sales ratio of 19.62x as of Friday, May 22, 2026. This represents a 56.73% decrease compared to its 12-month average of 45.34x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.